{
    "root": "693ebc6d-c671-4fd6-8bd4-622c8b72dc05",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Guanfacine",
    "value": "20250204",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "FUMARIC ACID",
            "code": "88XHZ13131"
        },
        {
            "name": "METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A",
            "code": "NX76LV5T8J"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "GUANFACINE HYDROCHLORIDE",
            "code": "PML56A160O"
        }
    ],
    "indications": "guanfacine extended-release tablets indicated treatment attention deficit hyperactivity disorder ( adhd ) monotherapy adjunctive therapy stimulant medications [ ( 14 ) ] .",
    "contraindications": "recommended dose : 1 mg 7 mg ( 0.05 0.12 mg/kg target weight based dose range ) daily morning evening based response tolerability ( 2.2 ) . begin dose 1 mg daily adjust increments 1 mg/week ( 2.2 ) . crush , chew break tablets swallowing ( 2.1 ) . administer high-fat meals , increased exposure ( 2.1 ) . substitute immediate-release guanfacine tablets mg-per-mg basis , differing pharmacokinetic profiles ( 2.3 ) . switching immediate-release guanfacine , discontinue treatment titrate guanfacine extended-release tablets directed ( 2.3 ) . discontinuing , taper dose decrements 1 mg every 3 7 days avoid rebound hypertension ( 2.5 ) .",
    "warningsAndPrecautions": "guanfacine extended-release tablets 1 mg white off-white , round shaped tablets “ rj70 ” debossed one side plain side . ndc : 72162-1798-1 : 100 tablets bottle storage - store 20° - 25° c ( 68° - 77° f ) [ usp controlled room temperature ] . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "guanfacine contraindicated patients history hypersensitivity reaction guanfacine extended-release tablets inactive ingredients , products containing guanfacine . rash pruritus reported .",
    "indications_original": "Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications\n \n  [see Clinical Studies (14)].",
    "contraindications_original": "Recommended dose: 1 mg to 7 mg (0.05 to 0.12 mg/kg target weight based dose range) once daily in the morning or evening based on clinical response and tolerability (2.2). Begin at a dose of 1 mg once daily and adjust in increments of no more than 1 mg/week (2.2). Do not crush, chew or break tablets before swallowing (2.1). Do not administer with high-fat meals, because of increased exposure (2.1). Do not substitute for immediate-release guanfacine tablets on a mg-per-mg basis, because of differing pharmacokinetic profiles (2.3). If switching from immediate-release guanfacine, discontinue that treatment and titrate with guanfacine extended-release tablets as directed (2.3). When discontinuing, taper the dose in decrements of no more than 1 mg every 3 to 7 days to avoid rebound hypertension (2.5).",
    "warningsAndPrecautions_original": "Guanfacine extended-release tablets 1 mg are white to off-white, round shaped tablets with “RJ70” debossed on one side and plain on the other side.\n                  \n                     NDC: 72162-1798-1: 100 Tablets in a BOTTLE\n                  \n                  Storage - Store at 20° - 25° C (68° - 77° F) [See USP Controlled Room Temperature].\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Guanfacine is contraindicated in patients with a history of a hypersensitivity reaction to guanfacine extended-release tablets or its inactive ingredients, or other products containing guanfacine. Rash and pruritus have been reported."
}